Basic research for pathogenesis of type 1 von Willebrand disease
Basic research for pathogenesis of type 1 von Willebrand disease
批准号:
12671011
负责人:
MATSUI Taei
金额:
$1.98万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
我们从不同ABO血型的正常人和1型血管性血友病(VWD)患者中筛选了能够识别血管性血友病因子(VWF)碳水化合物结构差异的凝集素。此外,我们还研究了蛇毒蛋白通过与VWF和血小板相互作用影响人止血的结构和功能。1)在检测的血型识别凝集素中,HPA和UEA-I分别可用于VWF上的A型和O(H)型糖链的检测和分离(BBA, 1525: 50- 57,2001)。我们发现唾液酸识别凝集素(SSA和SNA)和H结构识别凝集素(TJA-I和UEA-I)优先与来自O组和1型VWD血浆的VWF结合,这表明这些VWF含有更多的末端唾液酸残基和H结构。2)我们测定了特异裂解VWF的kaouthiagin的氨基酸序列,发现其富含cys的结构域具有功能性崩解素样活性(Biochemistry 40: 4503- 4511,2001)。我们已经确定了通过调节VWF诱导血小板聚集的bitscittin的晶体结构,发现它具有一个富含负电荷残基的中心凹结构,这意味着它可能是VWF的结合位点(Biochemistry 40: 13592-13597, 2001)。3)我们发现血浆中生理性VWF切割金属蛋白酶的缺乏会引起VWF亚基的超高分子质量多聚体的存在,从而导致先天性血栓性血小板减少性紫癜(TTP)。(Int。中华血液学杂志,21(4):391 - 398,2001。j .内科杂志。科学,75:25-34,2002)。
英文摘要
We have screened lectins that can recognize the difference in the carbohydrate structures on von Willebrand factor (VWF) from normal individuals with each ABO blood group and patients with type 1 von Willebrand disease (VWD). Furthermore, we have studied the structure and function of snake venom proteins affecting human hemostasis by interacting with VWF and platelet.1) Among blood group-reconizing lectins examined, HPA and UEA-I were useful for detection and fractionation of blood group A and O(H) sugar chains on VWF, respectively (BBA, 1525: 50-57, 2001). We have found that the sialic acid-recognizing lectins (SSA and SNA) and the H structure-recognizing lectins (TJA-I and UEA-I) preferentially bound to VWF from group O and type 1 VWD plasmas, suggesting that these VWFs contain terminal sialic acid residues and the H structure in a higher amount.2) We have determined the amino acid sequence of kaouthiagin which specifically cleaves VWF, and found that its Cys-rich domain has the functional disintegrin-like activity (Biochemistry 40: 4503-4511, 2001). We have determined the crystal structure of bitiscetin which modulates VWF to induce platelet aggregation, and found that it has a central conecave structure rich in negatively charged residues, implying that it might be the VWF-binding site (Biochemistry 40: 13592-13597, 2001).3) We have found that the deficiency of physiological VWF-cleaving metalloproteinase in plasma causes the presence of ultra-high molecular mass multimers of VWF subunits resulting in the Upshaw-Schulman syndrome (USS), the congenital thrombotic thrombocytopenic purpura (TTP). (Int. J. Hematol, 74: 101-108, 2001, Int. J. Hematol., 75: 25-34, 2002).
期刊论文(37)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
S.Kinoshita, et al.: "Upshaw-Schulman syndrome revisited : a congenital deficiency of von Willebrand factor-cleaving protease, and its correction with fresh frozen plasma"Int.J.Hematol.. 74. 101-108 (2001)
S.Kinoshita 等人:“Upshaw-Schulman 综合征重温:冯维勒布兰德因子裂解蛋白酶的先天性缺陷及其用新鲜冰冻血浆的校正”Int.J.Hematol.. 74. 101-108 (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
松井太衛(共著): "第7回血液アゴラ"メディカル・ジャーナル社. 85-91 (2000)
Tae Matsui(合著者):“7th Blood Agora”Medical Journal Inc. 85-91 (2000)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H. Yagi, et al.: "Plasma of patients with Upshaw-Schulman syndrome enhances the aggregation of normal platelets under high shear stress."Br. J. Haematol.. 115. 991-997 (2001)
H. Yagi 等人:“Upshaw-Schulman 综合征患者的血浆在高剪切应力下增强了正常血小板的聚集。”Br。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y. Sakurai, et al.: "Inhibition of human platelet aggregation by L-aminoacid oxidase purified from Naja naja kaouthia venom."Toxicon. 39. 1827-1833 (2001)
Y. Sakurai 等人:“从 Naja naja kaouthia 毒液中纯化的 L-氨基酸氧化酶抑制人血小板聚集。”Toxicon。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kinoshita, S., et al.: "Upshaw-Schulman syndrome revisited : a congenital deficiency of von Willebrand factor-cleaving protease, and its correction with fresh frozen plasma"Int.J.Hematol.. 74(1). 101-108 (2001)
Kinoshita, S., 等人:“Upshaw-Schulman 综合征重温:冯维勒布兰德因子裂解蛋白酶先天性缺陷及其用新鲜冰冻血浆的校正”Int.J.Hematol.. 74(1)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 37 条
Regulation of thrombus formation by modulating platelet-von Willebrand factor interaction
-
批准号:25461463
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2013
-
负责人:MATSUI Taei
-
依托单位:
Studies on the physiological function of sugar chains and the activation mechanism of human von Willebrand factor
-
批准号:09671139
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:1997
-
负责人:MATSUI Taei
-
依托单位:
Structure and function of ABO blood group antigens fond in human von Willebrand factor
-
批准号:06671118
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.15万
-
财政年份:1994
-
负责人:MATSUI Taei
-
依托单位:
国内基金
海外基金
金属蛋白酶ADAMTS-13对von Willebrand factor还原作用的机制研究
-
批准号:81300222
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:周洲
-
依托单位:
von Willebrand Factor在胃肠道恶性肿瘤血源性播散中的作用及机制研究
-
批准号:81372575
-
项目类别:面上项目
-
资助金额:16.0万元
-
批准年份:2013
-
负责人:李敏
-
依托单位:
通过研究von Willebrand Factor 在剪切场中的运动规律和构象改变探索剪切场诱导血小板活化的奥秘
-
批准号:10802005
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2008
-
负责人:高振岳
-
依托单位: